94 related articles for article (PubMed ID: 11152302)
1. Ion channel activation by SPC3, a peptide derived from the HIV-1 gp120 V3 loop.
Carlier E; Mabrouk K; Moulard M; Fajloun Z; Rochat H; De Waard M; Sabatier JM
J Pept Res; 2000 Dec; 56(6):427-37. PubMed ID: 11152302
[TBL] [Abstract][Full Text] [Related]
2. SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms.
Yahi N; Fantini J; Baghdiguian S; Mabrouk K; Tamalet C; Rochat H; Van Rietschoten J; Sabatier JM
Proc Natl Acad Sci U S A; 1995 May; 92(11):4867-71. PubMed ID: 7761414
[TBL] [Abstract][Full Text] [Related]
3. V3 loop-derived peptide SPC3 inhibits infection of CD4- and galactosylceramide- cells by LAV-2/B.
Moulard M; Mabrouk K; Martin I; Van Rietschoten J; Rochat H; Sabatier JM
J Pept Res; 1999 Jun; 53(6):647-55. PubMed ID: 10408339
[TBL] [Abstract][Full Text] [Related]
4. Correlation of antiviral activity with beta-turn types for V3 synthetic multibranched peptides from HIV-1 gp120.
Mabrouk K; Van Rietschoten J; Rochat H; Loret EP
Biochemistry; 1995 Jul; 34(26):8294-8. PubMed ID: 7599121
[TBL] [Abstract][Full Text] [Related]
5. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5.
Madani N; Kozak SL; Kavanaugh MP; Kabat D
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8005-10. PubMed ID: 9653130
[TBL] [Abstract][Full Text] [Related]
6. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop.
Zhu R; Meng Q; Zhang H; Zhang G; Huang LSM; Xu Y; Schooley RT; An J; Huang Z
Eur J Med Chem; 2022 Dec; 244():114797. PubMed ID: 36270088
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation.
Liu QH; Williams DA; McManus C; Baribaud F; Doms RW; Schols D; De Clercq E; Kotlikoff MI; Collman RG; Freedman BD
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4832-7. PubMed ID: 10758170
[TBL] [Abstract][Full Text] [Related]
9. Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials.
Barbouche R; Fenouillet E; Papandréou MJ; Kiény MP; Sabatier JM
J Pept Res; 1998 Oct; 52(4):283-8. PubMed ID: 9832306
[TBL] [Abstract][Full Text] [Related]
10. SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cells.
Barbouche R; Miquelis R; Sabatier JM; Fenouillet E
J Pept Sci; 1998 Dec; 4(8):479-85. PubMed ID: 9927254
[TBL] [Abstract][Full Text] [Related]
11. Different signaling pathway between sphingosine-1-phosphate and lysophosphatidic acid in Xenopus oocytes: functional coupling of the sphingosine-1-phosphate receptor to PLC-xbeta in Xenopus oocytes.
Noh SJ; Kim MJ; Shim S; Han JK
J Cell Physiol; 1998 Aug; 176(2):412-23. PubMed ID: 9648929
[TBL] [Abstract][Full Text] [Related]
12. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.
Deng X; Ueda H; Su SB; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
Blood; 1999 Aug; 94(4):1165-73. PubMed ID: 10438703
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
Zhou N; Luo Z; Luo J; Liu D; Hall JW; Pomerantz RJ; Huang Z
J Biol Chem; 2001 Nov; 276(46):42826-33. PubMed ID: 11551942
[TBL] [Abstract][Full Text] [Related]
15. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120).
Biard-Piechaczyk M; Robert-Hebmann V; Richard V; Roland J; Hipskind RA; Devaux C
Virology; 2000 Mar; 268(2):329-44. PubMed ID: 10704341
[TBL] [Abstract][Full Text] [Related]
16. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.
Lee C; Liu QH; Tomkowicz B; Yi Y; Freedman BD; Collman RG
J Leukoc Biol; 2003 Nov; 74(5):676-82. PubMed ID: 12960231
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
19. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
20. Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages.
Yahi N; Fantini J; Mabrouk K; Tamalet C; de Micco P; van Rietschoten J; Rochat H; Sabatier JM
J Virol; 1994 Sep; 68(9):5714-20. PubMed ID: 8057453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
